Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

adinazolam mesylate

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The pharmacokinetics and pharmacodynamics of adinazolam mesylate (10 mg), N‐desmethyl adinazolam mesylate (NDMAD, 10 mg), and… Expand
Is this relevant?
2004
2004
The mechanism of release from sustained-release adinazolam mesylate tablets was assessed by the Higuchi equation and by analysis… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
AbstractPurpose. This work describes diffusivity measurements of drug (adinazolam mesylate) and water in a variety of solutions… Expand
Is this relevant?
2004
2004
The pharmacokinetics and pharmacodynamics of adinazolam (AD) were evaluated in 21 elderly subjects (mean age, 69 ± 4 years) at… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
AbstractPurpose. A mathematical model is described for the prediction of the relative change in drug release rate as a function… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
A novel optical image analysis method was developed to examine the dynamic swelling behavior of hydroxypropyl methylcellulose… Expand
Is this relevant?
1990
1990
The tolerance, pharmacokinetics, and pharmacodynamics of adinazolam and N‐desmethyladinazolam (NDMAD) were assessed after single… Expand
Is this relevant?
1988
1988
: In 72 outpatients with DSM-III major depressive episode, adinazolam was superior to placebo in all measurements. Significantly… Expand
Is this relevant?
1987
1987
Adinazolam mesylate, a new triazolobenzodiazepine with antidepressant properties, was significantly superior to placebo based on… Expand
Is this relevant?
1986
1986
ABSTRACT In a 6‐week, randomized, double‐blind study, adinazolam mezylate (Deracyn® Tablets, The Upjohn Company) was compared… Expand
Is this relevant?